Page last updated: 2024-11-04

terazosin and Arterial Occlusive Diseases

terazosin has been researched along with Arterial Occlusive Diseases in 1 studies

Terazosin: induces decreased blood pressure; used in the treatment of benign prostatic hyperplasia

Arterial Occlusive Diseases: Pathological processes which result in the partial or complete obstruction of ARTERIES. They are characterized by greatly reduced or absence of blood flow through these vessels. They are also known as arterial insufficiency.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Elliott, WJ1

Other Studies

1 other study available for terazosin and Arterial Occlusive Diseases

ArticleYear
An individualized approach to the hypertensive patient with renal disease: six illustrative case studies.
    Journal of clinical pharmacology, 1995, Volume: 35, Issue:1

    Topics: Adrenergic alpha-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Arterial Occlusive Dis

1995